Company Filing History:
Years Active: 1997
Title: Innovations in Blood Treatment: The Invention of Roger J Elgas
Introduction
Roger J Elgas is an accomplished inventor based in Lakewood, Colorado, who has made significant contributions to the field of medical devices. With a focus on enhancing blood treatment technologies, Elgas has patented a device designed to improve the efficiency of oxygen transfer in blood, paving the way for advancements in medical treatment.
Latest Patents
Elgas holds a patent for a blood treatment device with a moving membrane. This innovative design affects mass transfer between blood and a fluid, particularly in its application for oxygenating blood. The device utilizes a membrane that is moved in a predestined manner, parallel to the blood flow, to augment the efficiency and rate of mass transfer. Notably, this movement steepens the oxygen concentration gradient while decreasing the thickness of the blood mass transfer boundary layer. This breakthrough improves the rate at which oxygen is transferred into the blood, enhancing the overall effectiveness of blood treatment procedures.
Career Highlights
Roger J Elgas's dedication to innovation is reflected in his role at the University of Colorado, where he works alongside leading professionals in the medical research field. His unique invention showcases a blend of engineering principles and medical science, harnessing technology to address critical health issues.
Collaborations
Throughout his career, Elgas has collaborated with notable colleagues such as William B Krantz and Robert R Bilodeau. These partnerships highlight the importance of teamwork in advancing research and developing new technologies in the medical field.
Conclusion
Roger J Elgas's contributions to the area of blood treatment exemplify the impact that dedicated inventors can have on healthcare. His innovative patent for a blood treatment device with a moving membrane stands as a testament to the ongoing quest for improved medical solutions, which can potentially benefit countless patients in need of advanced blood treatment technologies.